Efficacy, Tolerance, and Plasma Levels of Abiraterone and Its Main Metabolites in a Patient With Metastatic Castration-resistant Prostate Cancer With a Hepatic Transplant

Author(s):
Nuland, M. van; Janssen, J.M.; Hoek, B. van (0000-0001-6527-764X); Rosing, H.; Beijnen, J.H.; Bergman, A.M.
Published
2019
Publication type
Article / Letter to editor
HepatotoxicityLiver transplantMetaboliteProstate cancerTherapeutic drug monitoring
Date issued
2019-10-31
Language
English
Is part of
Clinical Genitourinary Cancer (2019), Vol. 17, no. 5, p. E893-E896
hdl
1887/120416
doi
10.1016/j.clgc.2019.05.026